Target intelligence / Profile preview

Ischemia-reperfusion injury (IRI)

Target
IRI
01

Overview

Ischemia-reperfusion injury is the tissue damage that occurs when blood supply returns to tissue after a period of ischemia or lack of oxygen. The absence of oxygen and nutrients during ischemia creates a condition where restoration of circulation results in inflammation and oxidative damage through induction of oxidative stress rather than (or along with) restoration of normal function. The pathophysiology involves multiple mechanisms including production of reactive oxygen species, inflammatory responses, microvascular injury with increased capillary permeability, and activation of various cell death pathways including apoptosis, necrosis, autophagy, and necroptosis. IRI is clinically significant in various conditions including myocardial infarction, stroke, organ transplantation, and limb injuries. Therapeutic approaches include pharmacological interventions, ischemic preconditioning, medical gases, vitamin therapy, and therapeutic hypothermia.

Other names
Reperfusion injuryReoxygenation injuryReperfusion syndrome
02

Mechanism of action

Reduction of reactive oxygen species, Inhibition of inflammatory mediators, Regulation of cell death pathways, Protection of mitochondrial function

03

Biological functions

InflammationOxidative stressCell deathMicrovascular dysfunctionEndothelial dysfunction
04

Disease associations

Cardiovascular diseaseStrokeOrgan transplantation complicationsCritical limb ischemiaMultiple organ dysfunction syndromeChronic wounds
05

Safety considerations

Potential for compartment syndromeSystemic inflammatory response syndromeIncreased pain and swelling after revascularization
06

Interacting drugs

Metoprolol

3 more in the full profile.

07

Biomarkers

Inflammatory cytokinesReactive oxygen speciesMarkers of cell death

Beyond the preview

Go deeper on Ischemia-reperfusion injury (IRI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ischemia-reperfusion injury (IRI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call